| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effect of early versus deferred antiretroviral therapy for HIV on survival.
|
N Engl J Med
|
2009
|
19.90
|
|
2
|
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.
|
Nature
|
2009
|
13.99
|
|
3
|
A high-density admixture map for disease gene discovery in african americans.
|
Am J Hum Genet
|
2004
|
10.87
|
|
4
|
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.
|
Science
|
2004
|
8.22
|
|
5
|
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.
|
Nat Genet
|
2002
|
7.58
|
|
6
|
Trends in cancer risk among people with AIDS in the United States 1980-2002.
|
AIDS
|
2006
|
7.08
|
|
7
|
Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
|
Nat Genet
|
2007
|
6.83
|
|
8
|
Cancer risk in people infected with human immunodeficiency virus in the United States.
|
Int J Cancer
|
2008
|
6.13
|
|
9
|
Merkel cell carcinoma and HIV infection.
|
Lancet
|
2002
|
4.72
|
|
10
|
Cancer burden in the HIV-infected population in the United States.
|
J Natl Cancer Inst
|
2011
|
4.69
|
|
11
|
Late presentation for human immunodeficiency virus care in the United States and Canada.
|
Clin Infect Dis
|
2010
|
3.72
|
|
12
|
The characterization of twenty sequenced human genomes.
|
PLoS Genet
|
2010
|
3.72
|
|
13
|
AIDS-related cancer and severity of immunosuppression in persons with AIDS.
|
J Natl Cancer Inst
|
2007
|
3.28
|
|
14
|
Influence of HLA-C expression level on HIV control.
|
Science
|
2013
|
3.27
|
|
15
|
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C.
|
Nat Genet
|
2009
|
3.03
|
|
16
|
AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.
|
Nat Med
|
2005
|
2.97
|
|
17
|
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.
|
Blood
|
2006
|
2.90
|
|
18
|
Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study.
|
J Acquir Immune Defic Syndr
|
2013
|
2.78
|
|
19
|
Human gut microbiome and risk for colorectal cancer.
|
J Natl Cancer Inst
|
2013
|
2.76
|
|
20
|
Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.
|
Clin Infect Dis
|
2012
|
2.50
|
|
21
|
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007.
|
JAMA
|
2011
|
2.31
|
|
22
|
Elevated risk of lung cancer among people with AIDS.
|
AIDS
|
2007
|
2.20
|
|
23
|
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines.
|
J Natl Cancer Inst
|
2003
|
2.19
|
|
24
|
KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.
|
PLoS Pathog
|
2006
|
2.06
|
|
25
|
Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America.
|
Clin Infect Dis
|
2009
|
2.05
|
|
26
|
Hemophilic siblings with chronic hepatitis C: Familial aggregation of spontaneous and treatment-related viral clearance.
|
Gastroenterology
|
2006
|
2.04
|
|
27
|
Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals.
|
Clin Infect Dis
|
2012
|
2.01
|
|
28
|
Screening the human exome: a comparison of whole genome and whole transcriptome sequencing.
|
Genome Biol
|
2010
|
2.00
|
|
29
|
APOBEC3G genetic variants and their influence on the progression to AIDS.
|
J Virol
|
2004
|
1.97
|
|
30
|
Immune deficiency and risk for malignancy among persons with AIDS.
|
J Acquir Immune Defic Syndr
|
2003
|
1.96
|
|
31
|
C-reactive protein and risk of lung cancer.
|
J Clin Oncol
|
2010
|
1.90
|
|
32
|
Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission.
|
J Infect Dis
|
2007
|
1.88
|
|
33
|
Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.
|
Ann Intern Med
|
2015
|
1.86
|
|
34
|
HLA-Cw*04 and hepatitis C virus persistence.
|
J Virol
|
2002
|
1.83
|
|
35
|
Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts.
|
Ann Intern Med
|
2013
|
1.82
|
|
36
|
Effects of CCR5-Delta32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection.
|
AIDS
|
2003
|
1.81
|
|
37
|
APOBEC3B deletion and risk of HIV-1 acquisition.
|
J Infect Dis
|
2009
|
1.74
|
|
38
|
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis.
|
J Acquir Immune Defic Syndr
|
2013
|
1.72
|
|
39
|
The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
|
Hepatology
|
2004
|
1.69
|
|
40
|
Hepatitis C virus load and survival among injection drug users in the United States.
|
Hepatology
|
2005
|
1.66
|
|
41
|
Role of hepatitis C virus infection in malignant lymphoma in Spain.
|
Int J Cancer
|
2004
|
1.61
|
|
42
|
Modulating influence on HIV/AIDS by interacting RANTES gene variants.
|
Proc Natl Acad Sci U S A
|
2002
|
1.61
|
|
43
|
Commentary: meta-analysis of individual participants' data in genetic epidemiology.
|
Am J Epidemiol
|
2002
|
1.59
|
|
44
|
Markers of microbial translocation and risk of AIDS-related lymphoma.
|
AIDS
|
2013
|
1.53
|
|
45
|
Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection.
|
J Virol
|
2003
|
1.52
|
|
46
|
Host immunogenetics and control of human herpesvirus-8 infection.
|
J Infect Dis
|
2006
|
1.52
|
|
47
|
Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers.
|
J Acquir Immune Defic Syndr
|
2005
|
1.51
|
|
48
|
249(ser) TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma.
|
Oncogene
|
2005
|
1.49
|
|
49
|
Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma.
|
AIDS
|
2003
|
1.49
|
|
50
|
IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection.
|
J Infect Dis
|
2010
|
1.48
|
|
51
|
Assessment of the human faecal microbiota: II. Reproducibility and associations of 16S rRNA pyrosequences.
|
Eur J Clin Invest
|
2012
|
1.43
|
|
52
|
Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression.
|
Int J Cancer
|
2010
|
1.42
|
|
53
|
Circulating serum free light chains as predictive markers of AIDS-related lymphoma.
|
J Clin Oncol
|
2010
|
1.36
|
|
54
|
Multistage genomewide association study identifies a locus at 1q41 associated with rate of HIV-1 disease progression to clinical AIDS.
|
J Infect Dis
|
2010
|
1.33
|
|
55
|
Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.
|
PLoS Pathog
|
2013
|
1.33
|
|
56
|
Mitochondrial DNA haplogroups influence AIDS progression.
|
AIDS
|
2008
|
1.29
|
|
57
|
Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus.
|
J Infect Dis
|
2010
|
1.28
|
|
58
|
Human immunodeficiency virus type 1 (HIV-1)-specific CD8+-T-cell responses for groups of HIV-1-infected individuals with different HLA-B*35 genotypes.
|
J Virol
|
2002
|
1.28
|
|
59
|
Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia.
|
Blood
|
2005
|
1.28
|
|
60
|
Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.
|
Hepatology
|
2010
|
1.28
|
|
61
|
Elevated risk for squamous cell carcinoma of the conjunctiva among adults with AIDS in the United States.
|
Int J Cancer
|
2008
|
1.27
|
|
62
|
Prevalence of Kaposi's sarcoma-associated herpesvirus infection in sex workers and women from the general population in Spain.
|
Int J Cancer
|
2002
|
1.27
|
|
63
|
Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda.
|
J Natl Cancer Inst
|
2003
|
1.26
|
|
64
|
Pulmonary infections and risk of lung cancer among persons with AIDS.
|
J Acquir Immune Defic Syndr
|
2010
|
1.25
|
|
65
|
A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection.
|
J Virol
|
2012
|
1.24
|
|
66
|
Polymorphisms of CUL5 are associated with CD4+ T cell loss in HIV-1 infected individuals.
|
PLoS Genet
|
2007
|
1.23
|
|
67
|
Reduced risk of prostate cancer in U.S. Men with AIDS.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.23
|
|
68
|
Aflatoxin exposure and viral hepatitis in the etiology of liver cirrhosis in the Gambia, West Africa.
|
Environ Health Perspect
|
2008
|
1.22
|
|
69
|
HLA-B*35-Px-mediated acceleration of HIV-1 infection by increased inhibitory immunoregulatory impulses.
|
J Exp Med
|
2009
|
1.22
|
|
70
|
Reactivation of Kaposi's sarcoma-associated herpesvirus by natural products from Kaposi's sarcoma endemic regions.
|
Int J Cancer
|
2007
|
1.21
|
|
71
|
Detection of kaposi sarcoma-associated herpesvirus DNA in saliva and buffy-coat samples from children with sickle cell disease in Uganda.
|
J Infect Dis
|
2004
|
1.21
|
|
72
|
Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.
|
J Virol
|
2006
|
1.17
|
|
73
|
HLA-B alleles associate consistently with HIV heterosexual transmission, viral load, and progression to AIDS, but not susceptibility to infection.
|
AIDS
|
2010
|
1.17
|
|
74
|
Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression.
|
Am J Hum Genet
|
2006
|
1.17
|
|
75
|
Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma.
|
Cancer
|
2006
|
1.17
|
|
76
|
Risk factors for classical Kaposi sarcoma in a population-based case-control study in Sicily.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
1.16
|
|
77
|
High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs.
|
J Infect Dis
|
2005
|
1.16
|
|
78
|
Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS.
|
J Infect Dis
|
2010
|
1.16
|
|
79
|
Genome-wide association study implicates PARD3B-based AIDS restriction.
|
J Infect Dis
|
2011
|
1.15
|
|
80
|
Risk factors for Kaposi's sarcoma among HHV-8 seropositive homosexual men with AIDS.
|
Int J Cancer
|
2005
|
1.14
|
|
81
|
Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future.
|
J Natl Cancer Inst
|
2005
|
1.14
|
|
82
|
CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?
|
AIDS Res Ther
|
2010
|
1.13
|
|
83
|
The relation of HLA genotype to hepatitis C viral load and markers of liver fibrosis in HIV-infected and HIV-uninfected women.
|
J Infect Dis
|
2011
|
1.13
|
|
84
|
Determinants of protection among HIV‐exposed seronegative persons: an overview.
|
J Infect Dis
|
2010
|
1.13
|
|
85
|
Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.
|
J Virol
|
2002
|
1.13
|
|
86
|
Real-time PCR assay for detection and quantification of hepatitis B virus genotypes A to G.
|
J Clin Microbiol
|
2006
|
1.13
|
|
87
|
Association of DC-SIGN promoter polymorphism with increased risk for parenteral, but not mucosal, acquisition of human immunodeficiency virus type 1 infection.
|
J Virol
|
2004
|
1.12
|
|
88
|
Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.12
|
|
89
|
Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening.
|
J Infect Dis
|
2011
|
1.11
|
|
90
|
Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China.
|
Int J Cancer
|
2008
|
1.11
|
|
91
|
Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.
|
J Virol
|
2002
|
1.11
|
|
92
|
Host genetic influences on highly active antiretroviral therapy efficacy and AIDS-free survival.
|
J Acquir Immune Defic Syndr
|
2008
|
1.09
|
|
93
|
HCV quasispecies evolution: association with progression to end-stage liver disease in hemophiliacs infected with HCV or HCV/HIV.
|
Blood
|
2004
|
1.08
|
|
94
|
Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS.
|
PLoS Pathog
|
2007
|
1.08
|
|
95
|
Chlamydia pneumoniae infection and risk for lung cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
1.07
|
|
96
|
Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
|
AIDS
|
2003
|
1.07
|
|
97
|
Antibody reactivity to latent and lytic antigens to human herpesvirus-8 in longitudinally followed homosexual men.
|
J Infect Dis
|
2002
|
1.06
|
|
98
|
A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.
|
Hum Mol Genet
|
2013
|
1.05
|
|
99
|
Anal microbiota profiles in HIV-positive and HIV-negative MSM.
|
AIDS
|
2014
|
1.04
|
|
100
|
MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission.
|
AIDS
|
2003
|
1.04
|
|
101
|
Immunological detection of viral large T antigen identifies a subset of Merkel cell carcinoma tumors with higher viral abundance and better clinical outcome.
|
Int J Cancer
|
2010
|
1.03
|
|
102
|
Regulatory polymorphisms in the interleukin-18 promoter are associated with hepatitis C virus clearance.
|
J Infect Dis
|
2008
|
1.03
|
|
103
|
Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica.
|
Clin Infect Dis
|
2002
|
1.03
|
|
104
|
Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis.
|
AIDS
|
2004
|
1.02
|
|
105
|
KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection.
|
PLoS Pathog
|
2011
|
1.02
|
|
106
|
Geographic heterogeneity of prevalence of the human herpesvirus 8 in sub-Saharan Africa: clues about etiology.
|
Ann Epidemiol
|
2010
|
1.02
|
|
107
|
HIV-associated Hodgkin lymphoma during the first months on combination antiretroviral therapy.
|
Blood
|
2011
|
1.02
|
|
108
|
Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.
|
PLoS One
|
2010
|
1.00
|
|
109
|
Prevalence of hepatitis C virus infection and risk for hepatocellular carcinoma and non-Hodgkin lymphoma in AIDS.
|
J Acquir Immune Defic Syndr
|
2002
|
0.99
|
|
110
|
Immunoblastic lymphoma in persons with AIDS-associated Kaposi's sarcoma: a role for Kaposi's sarcoma-associated herpesvirus.
|
Mod Pathol
|
2003
|
0.99
|
|
111
|
Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome.
|
Int J Immunogenet
|
2008
|
0.96
|
|
112
|
Genetic markers of IgG influence the outcome of infection with hepatitis C virus.
|
J Infect Dis
|
2008
|
0.95
|
|
113
|
Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites: a cross-sectional study.
|
J Transl Med
|
2012
|
0.94
|
|
114
|
Association of Y chromosome haplogroup I with HIV progression, and HAART outcome.
|
Hum Genet
|
2009
|
0.94
|
|
115
|
HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples.
|
AIDS
|
2007
|
0.94
|
|
116
|
HIV tropism and decreased risk of breast cancer.
|
PLoS One
|
2010
|
0.94
|
|
117
|
Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
0.93
|
|
118
|
Antibodies to JC and BK viruses among persons with non-Hodgkin lymphoma.
|
Int J Cancer
|
2005
|
0.93
|
|
119
|
Risk factors for human herpesvirus 8 seropositivity in the AIDS Cancer Cohort Study.
|
J Clin Virol
|
2006
|
0.93
|
|
120
|
Assessment of the human faecal microbiota: I. Measurement and reproducibility of selected enzymatic activities.
|
Eur J Clin Invest
|
2012
|
0.92
|
|
121
|
Seroprevalence and risk factors for human herpesvirus 8 infection, rural Egypt.
|
Emerg Infect Dis
|
2008
|
0.92
|
|
122
|
Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometry.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.92
|
|
123
|
Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1.
|
J Virol
|
2006
|
0.92
|
|
124
|
Cellular HIV-1 DNA load predicts HIV-RNA rebound and the outcome of highly active antiretroviral therapy.
|
AIDS
|
2004
|
0.92
|
|
125
|
Circulating cytokine levels, Epstein-Barr viremia, and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma.
|
Am J Hematol
|
2011
|
0.91
|
|
126
|
High frequency of CCR5-delta32 homozygosity in HCV-infected, HIV-1-uninfected hemophiliacs results from resistance to HIV-1.
|
Gastroenterology
|
2003
|
0.91
|
|
127
|
Risk of classic Kaposi sarcoma with residential exposure to volcanic and related soils in Sicily.
|
Ann Epidemiol
|
2009
|
0.91
|
|
128
|
Increased levels of circulating cytokines with HIV-related immunosuppression.
|
AIDS Res Hum Retroviruses
|
2011
|
0.90
|
|
129
|
Human papillomavirus genotypes among women with HIV: implications for research and prevention.
|
AIDS
|
2006
|
0.90
|
|
130
|
Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.
|
J Infect Dis
|
2003
|
0.90
|
|
131
|
Reconstitution of immune responses against Kaposi sarcoma-associated herpesvirus.
|
AIDS
|
2010
|
0.89
|
|
132
|
The association between cancer and amyotrophic lateral sclerosis.
|
Cancer Causes Control
|
2012
|
0.89
|
|
133
|
Influence of human leukocyte antigen-B22 alleles on the course of human immunodeficiency virus type 1 infection in 3 cohorts of white men.
|
J Infect Dis
|
2003
|
0.88
|
|
134
|
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.
|
AIDS
|
2013
|
0.86
|
|
135
|
Differences in Kaposi sarcoma-associated herpesvirus-specific and herpesvirus-non-specific immune responses in classic Kaposi sarcoma cases and matched controls in Sicily.
|
Cancer Sci
|
2011
|
0.86
|
|
136
|
Pleural and peritoneal lymphoma among people with AIDS in the United States.
|
J Acquir Immune Defic Syndr
|
2002
|
0.86
|
|
137
|
Transmission of Kaposi sarcoma-associated herpesvirus in sub-Saharan Africa.
|
AIDS
|
2008
|
0.86
|
|
138
|
Association of fecal microbial diversity and taxonomy with selected enzymatic functions.
|
PLoS One
|
2012
|
0.86
|
|
139
|
Re: "Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus".
|
Am J Epidemiol
|
2003
|
0.85
|
|
140
|
Associations of the fecal microbiome with urinary estrogens and estrogen metabolites in postmenopausal women.
|
J Clin Endocrinol Metab
|
2014
|
0.85
|
|
141
|
Genetic associations of variants in genes encoding HIV-dependency factors required for HIV-1 infection.
|
J Infect Dis
|
2010
|
0.84
|
|
142
|
Socio-economic and other correlates of Kaposi sarcoma-associated herpesvirus seroprevalence among older adults in Sicily.
|
J Med Virol
|
2009
|
0.84
|
|
143
|
Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia.
|
AIDS
|
2007
|
0.84
|
|
144
|
Merkel cell polyomavirus is not detected in mesotheliomas.
|
J Clin Virol
|
2009
|
0.83
|
|
145
|
Feasibility of self-collection of fecal specimens by randomly sampled women for health-related studies of the gut microbiome.
|
BMC Res Notes
|
2014
|
0.83
|
|
146
|
Correlates of Human Herpesvirus-8 DNA detection among adults in Italy without Kaposi sarcoma.
|
Int J Epidemiol
|
2005
|
0.83
|
|
147
|
Effect of CCR5-delta32 heterozygosity on the risk of perinatal HIV-1 infection: a meta-analysis.
|
J Acquir Immune Defic Syndr
|
2003
|
0.83
|
|
148
|
Role of exonic variation in chemokine receptor genes on AIDS: CCRL2 F167Y association with pneumocystis pneumonia.
|
PLoS Genet
|
2011
|
0.82
|
|
149
|
Interaction between RANTES promoter variant and CCR5Delta32 favors recovery from hepatitis B.
|
J Immunol
|
2008
|
0.82
|
|
150
|
An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1.
|
AIDS Res Hum Retroviruses
|
2013
|
0.81
|
|
151
|
Prevalence of toscana and sicilian phlebovirus antibodies in classic Kaposi sarcoma case patients and control subjects in sicily.
|
J Infect Dis
|
2011
|
0.81
|
|
152
|
Human herpesvirus 8 seroprevalence among children and adolescents in the United States.
|
Pediatr Infect Dis J
|
2008
|
0.81
|
|
153
|
Opportunistic intestinal infections and risk of colorectal cancer among people with AIDS.
|
AIDS Res Hum Retroviruses
|
2012
|
0.81
|
|
154
|
Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30.
|
Infect Agent Cancer
|
2010
|
0.81
|
|
155
|
The microbiota and human health: beyond exploration.
|
Eur J Clin Invest
|
2013
|
0.80
|
|
156
|
Kaposi's sarcoma-associated herpesvirus infection in elderly Jews and non-Jews from New York City.
|
Int J Epidemiol
|
2002
|
0.80
|
|
157
|
A common genetic variant in FCGR3A-V158F and risk of Kaposi sarcoma herpesvirus infection and classic Kaposi sarcoma.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
0.78
|
|
158
|
Immunoglobulin M seropositivity for Toscana virus in a random population sample in Sicily.
|
Int J Infect Dis
|
2012
|
0.78
|
|
159
|
Cohort- and time-specific associations of CTLA4 genotypes with HIV-1 disease progression.
|
AIDS
|
2006
|
0.78
|
|
160
|
Changes in T cell receptor excision DNA circle (TREC) levels in HIV type 1-infected subjects pre- and post-highly active antiretroviral therapy.
|
AIDS Res Hum Retroviruses
|
2004
|
0.77
|
|
161
|
Childhood exposure to simian virus 40-contaminated poliovirus vaccine and risk of AIDS-associated non-Hodgkin's lymphoma.
|
Int J Cancer
|
2003
|
0.77
|
|
162
|
Relationship between Kaposi sarcoma-associated herpesvirus and HIV.
|
JAMA
|
2002
|
0.77
|
|
163
|
Human herpesvirus 8 seropositivity in rural Uganda: maturation of sero-epidemiological studies.
|
J Infect Dis
|
2011
|
0.77
|
|
164
|
Examination of disease-based selection, demographic history and population structure in European Y-chromosome haplogroup I.
|
J Hum Genet
|
2010
|
0.76
|
|
165
|
HIV-associated lung cancer: ambiguities and challenges.
|
AIDS
|
2012
|
0.76
|
|
166
|
Reply to bibas et Al.
|
Clin Infect Dis
|
2013
|
0.75
|
|
167
|
Lymphocyte subsets in hemophilic patients with hepatitis C virus infection with or without human immunodeficiency virus co-infection: a nested cross-sectional study.
|
BMC Blood Disord
|
2005
|
0.75
|
|
168
|
Nonsmoking and other cofactors for Kaposi's sarcoma.
|
AIDS
|
2009
|
0.75
|
|
169
|
Recent trends and future directions in human immunodeficiency virus-associated cancer.
|
Cancer
|
2010
|
0.75
|
|
170
|
Peripheral blood immunologic phenotype of population-based breast cancer cases and matched controls.
|
Eur J Clin Invest
|
2011
|
0.75
|
|
171
|
Variants in HAVCR1 gene region contribute to hepatitis C persistence in African Americans.
|
J Infect Dis
|
2013
|
0.75
|
|
172
|
Tumor markers and treatments for Kaposi sarcoma.
|
AIDS
|
2007
|
0.75
|
|
173
|
A whole-genome analysis of premature termination codons.
|
Genomics
|
2011
|
0.75
|
|
174
|
Preventing infection-associated cancer: from bench to hillside.
|
J Natl Cancer Inst
|
2005
|
0.75
|
|
175
|
Invited Commentary: A Landmark Study Launched in a Public Health Maelstrom.
|
Am J Epidemiol
|
2017
|
0.75
|
|
176
|
Identifying Host Genetic Variants Associated with Microbiome Composition by Testing Multiple Beta Diversity Matrices.
|
Hum Hered
|
2017
|
0.75
|
|
177
|
Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applications.
|
JAMA
|
2014
|
0.75
|
|
178
|
The incidence of Kaposi sarcoma among injection drug users with AIDS in the United States.
|
J Acquir Immune Defic Syndr
|
2004
|
0.75
|
|
179
|
Associations of CD4+ T-cell count, HIV-1 RNA viral load, and antiretroviral therapy with Kaposi sarcoma risk among HIV-infected persons in the United States and Canada.
|
J Acquir Immune Defic Syndr
|
2017
|
0.75
|